13D-OWNERSHIP REPORTING

Company

Lineage Cell Therapeutics, Inc.

Filed

September 25, 1997

Accession Number

0000876343-97-000012

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →